Article
Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway.
PloS one - 1 Jan 2013
Nord Karolin H, Nilsson Jenny, Arbajian Elsa, Vult von Steyern Fredrik, Brosjö Otte, Cleton-Jansen Anne-Marie, Szuhai Karoly, Hogendoorn Pancras C W
Abstract excerpt
Osteoblastoma is a bone forming tumor with histological features highly similar to osteoid osteoma; the discrimination between the tumor types is based on size and growth pattern. The vast majority of osteoblastomas are benign but there is a group of so-called aggressive osteoblastomas that can be diagnostically challenging at the histopathological level. The genetic aberrations required for osteoblastoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
